hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study.
about
Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma.Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo.MiR-3613-3p affects cell proliferation and cell cycle in hepatocellular carcinoma.A Novel Hybrid Promoter ARE-hTERT for Cancer Gene Therapy.
P2860
hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study.
@en
hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study.
@nl
type
label
hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study.
@en
hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study.
@nl
prefLabel
hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study.
@en
hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study.
@nl
P2093
P2860
P356
P1433
P1476
hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study.
@en
P2093
Eugene D Sverdlov
Eugene P Kopantzev
Igor V Korobko
Mikhail V Shepelev
Tatiana V Vinogradova
P2860
P304
P356
10.3892/OL.2016.4718
P577
2016-06-15T00:00:00Z